Syros Pharmaceuticals Inc (SYRS)
5.13
-0.07
(-1.35%)
USD |
NASDAQ |
May 03, 16:00
5.13
0.00 (0.00%)
After-Hours: 20:00
Syros Pharmaceuticals Shareholders Equity (Quarterly): 16.66M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 16.66M |
| September 30, 2023 | 36.30M |
| June 30, 2023 | 73.24M |
| March 31, 2023 | 106.75M |
| December 31, 2022 | 127.74M |
| September 30, 2022 | 129.17M |
| June 30, 2022 | 31.02M |
| March 31, 2022 | 62.74M |
| December 31, 2021 | 85.22M |
| September 30, 2021 | 106.06M |
| June 30, 2021 | 129.98M |
| March 31, 2021 | 149.88M |
| December 31, 2020 | 90.55M |
| September 30, 2020 | 45.94M |
| June 30, 2020 | 62.41M |
| March 31, 2020 | 76.54M |
| December 31, 2019 | 79.18M |
| Date | Value |
|---|---|
| September 30, 2019 | 94.57M |
| June 30, 2019 | 111.92M |
| March 31, 2019 | 64.02M |
| December 31, 2018 | 78.59M |
| September 30, 2018 | 94.84M |
| June 30, 2018 | 108.71M |
| March 31, 2018 | 104.50M |
| December 31, 2017 | 65.32M |
| September 30, 2017 | 78.59M |
| June 30, 2017 | 91.08M |
| March 31, 2017 | 70.14M |
| December 31, 2016 | 80.60M |
| September 30, 2016 | 90.78M |
| June 30, 2016 | 53.39M |
| March 31, 2016 | 63.92M |
| December 31, 2015 | 34.05M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
16.66M
Minimum
Dec 2023
149.88M
Maximum
Mar 2021
85.05M
Average
85.22M
Median
Dec 2021
Shareholders Equity (Quarterly) Benchmarks
| PDS Biotechnology Corp | 26.13M |
| PAVmed Inc | -53.83M |
| Moderna Inc | 12.82B |
| Altimmune Inc | 194.10M |
| iBio Inc | 9.197M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 168.17M |
| Total Liabilities (Quarterly) | 151.51M |
| Debt to Equity Ratio | 2.474 |
| Current Ratio | 3.952 |
| Net Debt Paydown Yield | -0.07% |